3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
6
Sarcoma
1
Conditions
Dendritic Cell Sarcoma, Interdigitating
15
Lymphoma, Large B-Cell, Diffuse
9
Lymphoma
9
Burkitt Lymphoma
5
Lymphoma, Non-Hodgkin
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia
3
Sezary Syndrome
2
Recurrence
2
Primary Myelofibrosis
2
Myeloproliferative Disorders
2
Mycosis Fungoides
2
Multiple Myeloma
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Hairy Cell
2
Hodgkin Disease
2
Graft vs Host Disease
2
Blast Crisis
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Interventions
Doxorubicin
11
Zidovudine
9
Vincristine
8
Bleomycin
7
Liposomes
5
Interferon alpha-2
5
tecogalan
4
Etoposide
4
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Biopsy
3
sargramostim
2
interferon alfa-n1
2
Semaxinib
2
Rituximab
2
Ritonavir
2
Polymerase Chain Reaction
2
Nivolumab
2
Mitoxantrone
2
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
2
Didanosine
2
Alitretinoin
2
vesnarinone
1
tin etiopurpurin
1
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
1
pembrolizumab
1
nirogacestat
1
fludarabine phosphate
1
emvododstat
1
efineptakin alfa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
HIV Infections
×
Prednisone
×
Sarcoma
×
Clear all
NCT00799136
2013-09-12
CATCH
Ontario Clinical Oncology Group (OCOG)
Phase 2
Completed
6 enrolled